#tafamidis

[myperfectheart]

Tafamidis shows promise for treating cardiac amyloidosis

Tafamidis shows promise for treating cardiac amyloidosis

“We speculate that the higher hospitalization rate observed in this group is attributable to longer survival during a more severe period of disease, underscoring the importance of early diagnosis and treatment of this fatal, progressive disease, which can be difficult to diagnose,” Maurer et al. wrote. “Given the progressive nature of the disease and the mechanism through which tafamidis reduces…

View On WordPress

[lucadezzani]

Pfizer Announces Publication of New Analysis Showing the Effectiveness of Long-Term Therapy with VYNDAQEL (tafamidis) for the Treatment of Rare Neurodegenerative Disease

August 8, 2016

Pfizer Inc. has announced the publication of a new post-hoc analysis of data from three studies of VYNDAQEL in patients with mild transthyretin familial amyloid polyneuropathy (TTR-FAP). The analysis, which included patients with the Val30Met mutation treated over varying periods of up to 5.5 years, presented that treatment with VYNDAQEL started during the early stage of the…

View On WordPress